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Abstract
Purpose: Volumetric Modulated Arc Therapy (VMAT) is an intensity modulated radiation
therapy technique which can achieve highly conformal dose delivery through dynamic vari-
ation of dose rate, gantry speed, and multileaf collimator positions. Due to the complexity
of treatment delivery, patient specific quality assurance (QA) is required to ensure agreement
between calculated and delivered dose. Point dose measurements are a well established patient
specific QA technique for VMAT. The aim of this study was to investigate the relationship
between plan complexity and the agreement between measured and calculated point doses. The
suitability of five different detectors for VMAT point dose measurements was also evaluated.
Methods: 45 previously treated prostate VMAT plans were selected for the study. Isocentre
point dose measurements were carried out on a Varian iX linear accelerator using five com-
mercial detectors in the CIRS Model 009 Cube 20 phantom. Measurements were made with
IBA CC01 and CC04 compact ionisation chambers, IBA EFD3G and PFD3G diodes, and a
PTW 60019 microDiamiond detector. Detector measurement repeatability was investigated
and quantified by repeat measurements over three measurement sessions. The calculated dose
was computed in both Pinnacle, using both 4 degree and 2 degree per control point gantry
spacing (GS), and RayStation treatment planning systems. The agreement between measured
and calculated dose was evaluated for each detector and calculation algorithm. A selection of
established and novel aperture complexity metrics were calculated for the plan cohort. Correla-
tions between complexity metrics and point dose discrepancy results were investigated.
Results: A statistically significant difference in mean measured dose between the CC04
chamber and all other detectors was found at the 95% confidence level. The between measure-
ment sessions standard deviation was less than 0.5% of mean measured dose for all detectors
excluding the PFD3G. The CC01 achieved the greatest repeatability followed by the CC04,
EFD3G, microDiamond, and PFD3G. A statistically significant difference in mean calculated
dose was found for Pinnacle (both 4 and 2 degree GS) and RayStation calculation algorithms.
For both 2 degree and 4 degree GS the mean point dose discrepancy is less than 0.55% for all
detectors.
vi
Statistically significant linear relationships were found, with weak to moderate strength Pearson
correlation coefficients, for the following established complexity metrics MCSv, PI, PM, CAS,
CLS, and MAD metrics. The strongest Pearson correlation coefficient, r = 0.407, was found for
the PI metric with CC04 measured and Pinnacle 2 degree GS calculated dose. Evaluation of
plan complexity in progressively smaller ROI centred on the dose measurement and calculation
point increases the correlation strength for some complexity metrics.
Conclusion: Both the choice of a dose calculation algorithm and detector have a significant
influence on point dose discrepancy results. Consequently, the strength of correlations between
complexity metrics and point dose discrepancy is algorithm and detector specific. Therefore,
the utility of individual complexity metrics to identify plans likely to fail QA will be department
specific. The poor correlation strength of complexity metrics with point dose discrepancy
results limits their clinical usefulness in identification of plans likely to fail QA.
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Chapter 1
Introduction
Radiation therapy is an effective treatment for cancer when used alone or in conjunction with
other treatments such as chemotherapy and surgery. It is suggested that 52% of cancer patients
should receive radiation therapy at some stage of their treatment [1]. With new scanning
techniques allowing for earlier diagnosis it is expected that radiation therapy will become more
popular for the treatment of these localised malignancies [2]. The medical community must
therefore address this issue by maximising the efficiency of cancer therapy in regards to time
and cost.
1.1 Radiation Therapy
The general aim of radiation therapy is the eradication of cancer cells while sparing normal
tissue, to avoid complications (morbidity). The principle is best illustrated by the plotting of
tumour control probability (TCP) and normal tissue complication probability (NTCP) curves
as a function of dose, as displayed in figure 1.1. Absorbed dose is the mean energy imparted
per unit mass by ionising radiation and has units of gray (Gy), 1 Gy = 1 J kg−1. The optimal
radiation therapy dose for a given treatment will maximise TCP while minimising NTCP. The
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figure shows an ideal case, with a large separation between the two curves allowing high TCP
























Fig. 1.1 Sigmoidally shaped dose response curves for tumour control probability (TCP) and
normal tissue complication probability (NTCP). The therapeutic index (TI) is the ratio of
expected TCP to NTCP at a clinically mandated maximum tolerance (5% in this example).
The shape of the response curve is dependent on the radiobiology of both the tumour cells
and the normal tissue cells, and will depend on the treatment site. In some cases the TCP
curve is shallower than the NTCP curve, due to the highly heterogeneous nature of malignant
tissues, leading to a reduction in therapeutic index [3]. Modern radiation therapy allows the
maximisation of the therapeutic index through the use of highly conformal treatments. Dose to
malignant tissue is maximised while normal tissue is spared as much as possible, this can be
visualised as a shift of the TCP curve to the left.
1.1.1 Linear Accelerators
Modern external beam radiation therapy (EBRT) is most commonly delivered by mega-voltage
(MV) medical linear accelerator (linac) systems. Medical linacs can produce both electron and
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photon beams for radiation treatment. The isocentre is defined as the point in space in which
the linac gantry, collimators, and treatment couch rotate. The path through the waveguide
and linac head for a treatment beam can be seen in figure 1.2. Within a linac, electrons are
Fig. 1.2 Diagram of linear accelerator head components, reproduced from RayStaion 5 Refer-
ence Manual.
accelerated cyclically along a straight line path in the accelerating waveguide to energies of 6
- 18 MeV. Through the use of electric and magnetic fields, the beam transport system steers
and focuses the electrons into a narrow and approximately mono-energetic beam. The electron
beam is directed onto the primary target and produces a spectrum of Bremsstrahlung photons,
with mean energy approximately one third of the maximum incident electron energy. The
primary target can be thought of as a point photon source. The photon fluence generated from
the primary photon source is then attenuated by a flattening filter to produce a beam with flat
profile. The beam is then collimated to the desired shape via the combination of a primary
collimator, moveable collimator jaws, and finally through a multi-leaf-collimator (MLC). The
collimator jaws consist of thick tungsten blocks which define the maximum rectangular extent
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of the treatment field.
The MLC consists of 2 banks of opposing tungsten leaves which can be retracted or extended
into the beam. Neighbouring MLC leaves can move independently to define complex shapes,
allowing the beam to conform to the target in two dimensions. Figure 1.3 shows a Varian
Millennium 120 leaf MLC (Varian Medical Systems, Palo Alto, USA).
Fig. 1.3 Varian Millennium 120 leaf MLC, reproduced from Varian.
MLC leaf width is defined by their projected width at isocentre, ranging from 5 mm to 10
mm for non-stereotactic systems. To ensure constant attenuation with off-central-axis position,
MLC leaves used in Varian linear accelerators have rounded leaf tips. The MLC does not
provide perfect collimation of the primary beam, there will be some degree of inter- and
intraleaf transmission. Tongue-and-groove construction is used to reduce interleaf transmission
in the Varian system. Linac output is expressed in monitor units (MU), the calibration procedure
is explained further in section 2.5.2.
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1.1.2 Dose Calculation
Three major interaction processes occur within the patient for therapeutic photon beams: the
photoelectric effect, Compton scattering, and pair production [4]. These interactions lead to
attenuation and scattering of the incident photon beam within the patient. The photon radiation
used in EBRT is not directly ionising. The interaction of incident photons with matter causes
the liberation of directly ionising particles (electrons). It is these directly ionising particles
which transfer energy along their ionisation track, and therefore dose, to the medium.
The calculation of dose and planning of radiation therapy treatments is undertaken electronically
using a treatment planning system (TPS). Modern TPS dose calculation algorithms are model-
based, where measured beam data is used to characterise the beam attributes. Dose profiles are
measured in water at various depths for a selection of field sizes during commissioning of the
linac and TPS. Figure 1.4 shows a series of cross axis field profiles and depth dose profiles for
a 6 MV photon beam (6X), the measured dose profiles vary with beam energy, field size. and
measurement depth [5].
The process of adjusting beam model parameters to increase the agreement between measured
dose and calculated dose is known as beam modelling. These beam model parameters include
the size and position of the primary source, the energy spectrum of the photon source, and
parameters specific to the collimation system. Once the sufficient level of agreement between
measured and calculated dose is achieved the measured data is no longer used. This allows the
accurate calculation of dose for arbitrary beam configurations and geometry. The effect of beam
modifiers, patient surface, and tissue inhomogeneity on dose distributions can be accounted for
using a model based algorithm.
The first step of dose calculation is the computation of the energy fluence distribution from the
linac. The computation considers the path of photon radiation from the primary source through
the linac and accounts for the influence of the flattening filter and collimation systems which
were characterised in the beam modelling process. A secondary source is used to model the
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scattered radiation produced within the accelerator head. Model parameters used to characterise
the linac differ between treatment planning systems, and depend on the implicit assumptions
and simplifications of each algorithm.
Both treatment planning systems in this study make use of a collapsed cone convolution
superposition algorithm for final dose calculation. The following section will provide a basic
overview of the algorithm; refer to following references for a more in-depth description [6–
9]. The algorithm separates the primary photon transport and the secondary transport of the
photons and electrons generated by the primary photon interactions. The most common primary
interaction for MV photon beams in tissue is Compton scattering, producing a free electron and
a lower energy photon. The free electron deposits energy via ionisation within a short range of
the primary interaction. Pre-calculated point spread kernels are used to characterise the spatial
energy distribution resulting from each primary interaction. For a homogeneous medium and









is the linear mass attenuation coefficient at position r′, Ψ(r′) is the photon energy
fluence, and A(r− r′) is the point spread kernal.




gives the total energy per mass unit (TERMA). Therefore the dose distribution is given by
the convolution of primary energy deposits (TERMA) with secondary energy deposits in the
volume surrounding the primary interaction, characterised by the point spread kernel.
The algorithms used in both commercial treatment planning systems investigated account
for tissue inhomogeneities and the divergent nature of the beam. TERMA is computed by
the projection of the incident poly-energetic energy fluence through a density representation
(computed tomography scan) of the patient. Dose is then computed via 3-D superposition of the
TERMA with density scaled point spread kernels to account for tissue heterogeneities. A more
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in-depth discussion of each algorithm can be found in the Pinnacle 9.10 Physics Reference
Guide and the RayStation 5 Reference Manual [10, 11].
1.1.3 Intensity Modulated Radiation Therapy
Traditionally external beam photon radiation therapy consisted of the delivery of treatment
beams with uniform intensity across the field. The process of selecting a suitable beam
arrangement to produce the prescribed dose distribution is known as forward treatment planing.
Wedges and compensators were used to modify the intensity profile of these beams to achieve
a desired dose distribution within the target. While these simple techniques do modulate the
intensity of the treatment field, they are not included in what has become known as intensity
modulated radiation therapy (IMRT). The principle of IMRT is to modulate the intensity of
incident radiation in order to achieve a higher degree of conformity for the resulting dose
distribution and the target volume. The theoretical framework of the technique can be traced
back to 1982 when Brahme proposed what is now known as the definition of the inverse
planning problem in IMRT: “What is the desired lateral dose profile in the incident beam that
produces a desired absorbed dose distribution in the body?” [12]. The beam modulation is
optimised to increase the intensity of incident radiation passing through the target volume while
also reducing the intensity of incident radiation travelling through normal tissue. This results
in both increased target volume dose and reduced dose to critical structures around the target
volume compared to conventional radiation therapy [13]. The improved target dose conformity
results in better locoregional control, while the increased sparing of normal tissue leads to the
reduction of both acute and late toxicity [14].
In modern IMRT, beam modulation is achieved through either step-and-shoot or dynamic MLC
(DMLC) techniques. In step-and-shoot IMRT, the beam is halted while MLC leaves move to
designated positions then remain stationary while the beam is on; this process is repeated for
all segments in each beam. In DMLC delivery the MLC leaves move continuously, at variable
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speeds, while the beam is on, reducing treatment time when compared with step-and-shoot
IMRT. In both step-and-shoot and DMLC IMRT the gantry angle is static for each beam. The
desired final dose distribution results from the superposition of dose from each individual beam
segment. Often over 100 segments are defined across all beams in a treatment plan.
Traditional forward planning methods are unsuitable for the generation of IMRT, leading
to the development of inverse planning first proposed by Brahme. The planner will specify
clinical objectives for target volumes, often including maximum and minimum dose and dose to
volume constraints. Similarly for healthy organs and critical structures, the planner will specify
limiting dose constraints. An inverse planning optimisation algorithm can be broken down into
two main components: an objective function which encapsulates the clinical objectives and a
method to maximise/minimise the objective function. The inverse planning algorithm will then
analytically, or through iterative methods, optimise intensity profiles in order to generate a dose
distribution which fulfils the clinical objectives. The optimisation process is viewed as a “black
box” and therefore verification of the resultant treatment plan is required, as discussed further
in section 1.2.
1.1.4 Volumetric-Modulated Arc Therapy
Intensity modulated arc therapy (IMAT) was first proposed in 1995 [15]. Yu described and
demonstrated feasibility for this technique in which the gantry is rotated around the patient
while delivering radiation and the overlapping of multiple arcs provided intensity modulation.
Until relatively recently implementation of the technique was limited, with linac control sys-
tems and inverse treatment planning tools not being sufficiently robust for clinical use.
Now both Elekta (Elekta, Stockholm, Sweden) and Varian offer linacs capable of delivering
IMAT. Commercial availability along with improvements in inverse treatment planning systems
and increasing computational power make the deliverability of IMAT clinically feasible. Volu-
metric modulated arc therapy (VMAT) is an extension of IMAT to include dynamic variation of
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dose rate, gantry rotation speed, and MLC positions to deliver highly conformal dose to target
structures [16]. The variation of these extra parameters allows treatment to be delivered over a
fewer number of arcs than IMAT, greatly improving the time efficiency of the treatment. The
reduction in treatment time and MU, when compared to conventional IMRT, also leads to a
reduction in integral radiation dose to the rest of the body by reducing linac head leakage [17].
Like conventional IMRT, inverse planning is used to generate VMAT plans. The optimisation
and dose calculation algorithms for the two treatment planning systems used at Auckland City
Hospital are discussed in section 2.2.
1.2 Patient Specific Quality Assurance
Due to the complex nature of IMRT and VMAT treatment delivery and dose calculation when
compared to traditional 3D conformal radiation therapy there is increased uncertainty in the
agreement between the TPS calculated dose and delivered dose for IMRT and VMAT. IMRT
plans consist of complex arrangements of many small and irregular MLC field segments.
Therefore, accurate MLC leaf positioning (and leaf speed for DMLC) during delivery must be
assured. VMAT represents an even more complicated scenario by the inclusion of dynamic
gantry rotation and dose rate variation. Along with concerns of treatment deliverability, accurate
dose calculation for VMAT is challenging [18]. Therefore pre-treatment patient specific quality
assurance (QA) is performed to verify the agreement between TPS calculated dose and delivered
dose measured in phantoms.
The QA process typically involves the calculation of dose for the patient specific treatment
plan on a CT scanned phantom; calculated dose is then compared with measurements made
on the phantom. The AAPM Task Group 120 report provides recommendations for the use of
dosimeters, phantoms, and dose distribution analysis techniques during IMRT/VMAT quality
assurance [19]. Two measurement approaches are commonly used for dosimetric evaluation
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of IMRT/VMAT treatment plans: two-dimensional dose plane measurements and point dose
measurements.
1.2.1 Planar Dose Analysis
Two-dimensional dose plane measurements, using film or chamber arrays, provide dosimetric
and spatial information of the delivered dose distribution. The agreement between dose
distributions can be characterised by both the dose-difference at each dose grid point and
the distance-to-agreement, which is a measurement of the distance discrepancy between two
dose distributions. Gamma analysis combines both dose-difference and distance-to-agreement
criteria into a single index; the percentage of dose grid points meeting the specified criteria
[20, 21]. Auckland City Hospital requires at least 95% of points meet the (3% / 3 mm) dose-
difference and distance-to-agreement criteria for absolute gamma; the pass rate is relaxed to
85% for the stricter (2% / 2 mm) criteria.
Limitations of gamma analysis alone for patient specific QA have been summarised in the
literature [22]. The sensitivity of gamma analysis in detecting dosimetric errors has been shown
to strongly depend on the choice of analysis criteria. For example, it has been shown that the
(3% / 3 mm) criteria is insufficient to detect some introduced systematic errors [23, 24].
1.2.2 Point Dose Analysis
Point dose measurements provide a measurement of absolute dose at a pre-determined point of
interest (POI), typically within the target volume. In point dose measurements a detector is
placed within a phantom to measured absolute dose at the POI, which is then compared with
the TPS calculated dose at the POI. The discrepancy between the measured and TPS calculated
dose is subsequently evaluated; at Auckland City Hospital agreement must be within 3% for all
clinical IMRT and VMAT plans.
Kry et. al evaluated the sensitivity of point dose measurements and planar dose analysis (using
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both film and diode arrays), in the detection of dosimetric errors in IMRT delivery [25]. The
combination of both point dose measurement and planar analysis achieved sensitivity of 54%,
point dose measurements alone resulting in 25%, and planar analysis alone using a diode array
only 14%. These results highlight the importance of supplementing planar dose measurements
with point dose measurements to maximise the ability to detect dosimetric errors.
1.2.3 Plan Complexity Metrics
The degree of beam modulation can be considered analogous to the complexity of the control
points, and indeed the entire treatment plan. Various studies have outlined the disadvantages
associated with highly complex treatment plans; these include increased beam on time leading
to increased risk of patient movement, increased mechanical stress on the treatment unit, and
higher probability of the actual delivered dose deviating from the planned dose [26, 27].
Patient specific QA is time consuming and serious concerns have been raised over the sensitivity
of existing measurement methods in detecting clinically relevant errors. The development of
a method to identify treatment plans likely to fail QA would allow more efficient use of the
limited machine and physicist time. Many complexity metrics have been proposed in order to
characterise treatment plans and identify those likely to fail QA. Two general approaches have
emerged: direct analysis of beam aperture or analysis of the resulting plan intensity fluence
maps. Aperture based metrics represent the most direct method to investigate the influence
of key plan parameters on both TPS calculation and treatment machine deliverability, and are
therefore investigated in this study.
1.3 Radiation Dosimeters
In order to measure absorbed dose in a medium, the introduction of a radiation sensitive device
into the medium is required. Generally the sensitive volume of the detector will be constructed
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of a material different from the medium of interest. Cavity theory has been developed to relate
the absorbed dose measured within the detector’s sensitive volume to the absorbed dose in the
medium. Spencer-Attix-Nahum cavity theory is an extension of work by Louis Harold Gray
and William Lawrence Bragg, and accounts for deviations from the idealised formulation of
Bragg-Gray cavity theory [28].
Bragg-Gray cavity theory describes an idealised situation where the following conditions are
met:
1. The volume of the cavity is small when compared to the range of incident charged
particles as to not perturb the fluence of charged particles in the medium;
2. Absorbed dose in the cavity is only deposited by charged particles crossing the cavity.
The first condition implies the electron fluence within the cavity is equal to the equilibrium
fluence in the surrounding medium. This condition is only met in regions of charged particle
equilibrium (CPE), where the number of charged particles leaving a volume is equal to the
number entering. While the second condition rules out the production of secondary electrons
within the cavity, all dose is due to electrons crossing the cavity and no electrons stop within














is the ratio of the mean unrestricted mass
collision stopping powers of the medium and the cavity.
Spencer-Attix-Nahum cavity theory extends Bragg-Gray cavity theory to account for secondary
electrons (delta rays) produced by hard collisions between the primary electrons and cavity
material. This results in modifications to the formulation of stopping power ratios, and increased
agreement with experimental results when compared to Bragg-Gray Cavity theory [29, 30].
Modern dosimetry protocols, including IAEA TRS-398 (followed at Auckland City Hospital),
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are based on the Spencer-Attix-Nahum formulation which is applicable to megavoltage photon
and electron beams [31–33]. Detector response in standard reference conditions (10 × 10 cm2
field at 10 cm depth) is well characterised by these dosimetry protocols due to the presence of
CPE or transient CPE, thereby meeting the Bragg-Gray conditions. But VMAT plans often
consist small and irregular fields, which differ greatly from standard open field reference
conditions. Lateral electronic disequilibrium is observed in the small fields often found in
VMAT treatments [34, 35]. VMAT treatment plans often require steep dose gradients to achieve
the desired target dose while sparing organs at risk. These conditions pose a challenge for
point dose measurements as volume averaging effects are significant in high dose gradients
(especially for ionisation chambers). The non-uniformity of response within the detector
volume and perturbation factors should also be considered [36].
It is for these reasons dose measurements in VMAT fields are challenging, in this study the
suitability of five detectors for VMAT point dose measurements have been investigated. The
five detectors fall into three main classes of detector; ionisation chambers, silicon diodes, and
synthetic single crystal diamond detectors.
1.3.1 Ionisation Chambers
Energy from an incident ionising radiation beam is deposited by the production of ion pairs
within the medium. The basic construction of an ionisation chamber consists of a gas filled
cavity surrounded by a conductive outer wall and central charge collecting electrode. A
polarising voltage is applied across outer wall and central electrode to ensure ion pairs are
collected. Polarising voltages are of the order of a few hundred volts to ensure efficient
collection (typically between 95% and 100%) but avoid secondary ion pair production by the
motion of primary ion pairs [37]. Leakage currents are reduced by the addition of a guard
electrode. The mean dose deposited, D, within the mass of air, m, enclosed by the chamber is
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where e is the elementary charge, Pion is a correction factor for the recombination of ions within
the charge collection volume, and W is the mean ionisation energy in air. Therefore, dose can
be determined by the measurement of charge using an electrometer connected to the ionisation
chamber.
1.3.2 Silicon Diodes
Silicon diodes used in radiation dosimetry consist of a disc of p-type silicon counter-doped with
a thin layer of n-type silicon, to form a p-n junction diode. At the interface of the n- and p-type
material diffusion of majority carriers (electrons from n-region leaving positively charged
donor ions, and holes from the p-region leaving negatively charged acceptor ions) across the
junction takes place, forming the depletion region. Equilibrium is reached when the electric
field created across the depletion region by the donor ions opposes further flow of majority
carriers. Electron-hole pairs are created during irradiation within the body of the dosimeter
(including the depletion zone). Minority carriers produced within a diffusion length diffuse
into the depletion region, otherwise recombination occurs [38]. The length of the sensitive
region of the detector is therefore the depletion region length plus the diffusion length of the
minority carriers. The intrinsic potential across the depletion region makes charge collection
possible without the requirement of external bias voltage. See figure 1.5 for schematic of the
use of a p-n junction diode as a radiation detector. Charge carriers are accelerated across the
depletion region by the electric field resulting from the intrinsic potential. There exists a linear
relationship between the measured charge and dose when the diode is operated in short circuit
mode.
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The relative efficiency per unit volume for silicon diodes is on the order of 104 times greater
than an air ionisation chamber [39]. This is the result of two factors: Si is approximately 2000
times denser than air, and the mean ionisation energy for Si is approximately a tenth of that
in air (around 3 eV). This allows the construction of Si diode dosimeters with much smaller
sensitive volumes when compared with ionisation chambers.
1.3.3 Synthetic Single Crystal Diamond Detector
The use of diamond detectors in small field dosimetry is well established [40]. Diamond
detectors achieve spatial resolution comparable with silicon diodes, but provide superior tissue
equivalence and radiation hardness (resistance to radiation damage). The band gap for natural
diamond is approximately 5 times larger than silicon (5.54 eV versus 1.12 eV for silcon),
resulting in lower leakage currents due to fewer free charge carriers at room temperature.
When diamond is irradiated, a temporary change in electrical conductivity is observed resulting
from the production of electron and hole pairs which have sufficient energy to traverse the
crystal. The use of natural diamond crystals for dosimetry is impacted by low availability and
reproducibility of ’detector grade’ crystals and the high costs associated.
These challenges motivated the development of synthetic single crystal diamond detectors
(SCDDs) produced by chemical vapour deposition (CVD) by Marinelli et. al at the Industrial
Engineering Department of Rome Tor Vergata University in Italy [41]. The detectors consist of
a multi-layered metal/nominally intrinsic/p-type structure, as seen in figure 1.6. It was found
that the if barrier junction is located between the Al contact and the nominally intrinsic diamond
layer, the detector acts as a Schottky barrier photodiode which can be operated with both zero
bias voltage (photovoltaic mode) or with a positive voltage applied to the Al contact. When
the detector is irradiated in photovoltaic mode the total signal consists of electron/hole pairs
generated in the depletion region and charges generated in the neutral zone that have diffused
into the depletion region.
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1.4 Objectives
The patient specific quality assurance requirements for VMAT are greater than for traditional
3D-conformal treatments. An increasing proportion of patients are being treated with VMAT
at Auckland City Hospital, including palliative treatments. The increase in physics workload
spent on QA of these VMAT treatments is unsustainable, therefore the VMAT QA process
must be optimised. This requires a deeper understanding of the relationship between calculated
dose and measured dose in terms of plan complexity.
The main goal of this project will be to identify and develop an understanding of the salient
parameters influencing plan complexity and the impact of these on the accuracy of point dose
measurements in VMAT fields. The choice of detector for the point dose measurement will
also be explored. The research will allow especially complex treatment plans to be identified
during planning and potentially influence the patient specific quality assurance undertaken.
Point dose measurements will be remeasured for a cohort of past clinical treatment plans.
The influence of treatment planning system dose calculation on point dose results will be
investigated. Detector choice will be investigated concurrently by comparing results for various
detector types; small volume ionisation chambers, diodes, and synthetic diamond detectors will
be compared. Analysis of both repeatability and agreement with treatment planning system
calculation will be undertaken for each detector.
Software to read and extract essential information from DICOM-RT files generated by the
treatment planning system will be developed. Existing complexity metrics proposed in the
literature will then be calculated. Analysis of these against point dose measurement results
will allow key parameters to be identified and will steer development of additional complexity
metrics. Finally, this study will determine whether complexity metrics can be used to reliably
predict quality assurance results.
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Fig. 1.4 Example beam dose profile measurements used in TPS commissioning of a 6X beam,
square field size given in legend. Top: measurements of dose profile across the treatment field
at 10 cm depth. Bottom: the variation of dose with depth, normalised to dose maximum.
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Fig. 1.5 Schematic of a silicon diode dosimeter. Incident ionising radation produces electron-
hole pairs in the body of the dosimeter and within the depletion region. Excess minority carriers
created in the body of the dosimeter within one diffusion length, ln and lp, for p-type and n-type
respectively, diffuse into the depletion region. Carriers are swept across junction by intrinsic
potential, φo, net current flows in reverse direction of diode.
Fig. 1.6 Schematic of the synthetic single crystal diamond detector. Reproduced from Almaviva




All VMAT plans investigated in this study were planned and delivered clinically at Auckland
City Hospital between April and June 2015. The plans were generated using the SmartArc
module in Pinnacle3 (Version 9.8 and 9.10, Philips Medical, Fitchburg WI) following depart-
mental planning protocols, using 6 MV photons. Treatment doses were calculated using the
collapsed cone convolution superposition algorithm. The plans were optimised using 4 degree
gantry angle spacing between control points with a 3 mm resolution dose grid. All plans were
delivered using Varian iX linear accelerators with Millennium 120-leaf MLC (Varian Medical
Systems, Palo Alto, USA).
It has been shown that treatment plan complexity correlates strongly with target site and shape
[43]. In order to isolate the dosimetric impact of overly modulated treatment plans the decision
was made to limit this study to a single treatment site. A cohort of 45 prostate single arc 6X
VMAT plans were selected at random. Two standard prescriptions were present in the 45 plans.
23 with a prescription of 74 Gy to prostate PTV with 65 Gy to seminal vesicle PTV in 37
fractions, and 78 Gy to prostate PTV in 39 fractions for the remaining plans.
20 Methods and Materials
2.2 TPS Dose Calculation
Two commercial treatment planning systems are commissioned for clinical external beam
radiation therapy at Auckland City Hospital; Pinnacle and RayStation (Version 4.5, RaySearch
Laboratories, Stockholm, Sweden).
2.2.1 Pinnacle
The SmartArc module makes use of an optimisation algorithm developed by Bzdusek et al [44].
The optimisation process begins with the generation of a coarse set of segments spaced in 24
degree intervals within the user defined arc. Intensity modulation optimisation is carried out
for each segment and resulting fluence maps are converted to sliding window MLC segments.
The MLC segments are filtered, redistributed, and finally interpolated across the arc to achieve
evenly spaced 8 degree CP spacing. These control points are used in the Direct Machine Pa-
rameter Optimisation (DMPO), which is applied to leaf positions, MU, dose-rate, and delivery
time for each control point. The optimisation is constrained by the machine specifications,
such as maximum gantry speed, MLC leaf speed, and leaf travel per degree. Another linear
interpolation is carried out to generate a second set of control points to achieve the user defined
angular spacing. These control points are not part of the DMPO and are only used to increase
dose computation accuracy, they must be regenerated every time dose is computed. A fast
pencil beam algorithm, based on singular value decomposition, is used for dose calculation
during optimisation to keep computational time clinically acceptable. After machine parameters
have been optimised, the collimator jaws are set to the extent of the largest open leaf positions
across all segments.
Final dose calculation is performed using the collapsed cone convolution superposition al-
gorithm at user defined control points. Various authors have postulated that an increase in
dosimetric agreement can be achieved by reducing the gantry angle sampling interval for final
dose calculation [45]. This comes at the expense of longer calculation times. For clinical plans,
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Auckland City Hospital currently uses 4 degree gantry angle spacing between control points as
a compromise between calculation accuracy and speed. For final dose calculation in this study,
the plans were recalculated with using interpolated 2 degree gantry angle sampling, so that the
4 degree and 2 degree calculations could be compared.
2.2.2 RayStation
RayStation differs from Pinnacle in that dose is not calculated at each control point for VMAT
treatment plans. Instead, the dose calculation is split into arc segments which represent the
region between two control points. These arc segments are further divided into sub-segments
of equal angle to ensure maximum MLC leaf travel within each sub-segment is less than 1.5
cm. The monitor units of the arc segment are distributed over sub-segments and MLC leaf
positions are interpolated to the centre position of each sub-segment. The fluence of each
sub-segment is calculated and summed to obtain the arc segment fluence, which is then applied
to the centre position of the arc segment for dose calculation. TERMA is calculated by tracing
the arc segment fluence into the patient at the mean gantry angle of the segment. In order to
decrease computation time, TERMA is then accumulated over 10 degree gantry angle intervals.
Sphere point spread kernel tracing is performed at the middle of each accumulated region.
The RayStation beam model was not commissioned using the same beam measurement data
as the Pinnacle beam model. Therefore, RayStation provides an independent dose calculation
method to compare with doses calculated in Pinnacle. All treatment plans in this study were
recalculated in RayStation to investigate the influence of dose calculation algorithm on the
correlation of complexity metrics and point dose measurement results.
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2.3 Quantification of Plan Complexity
In-house software was developed in MATLAB (Version R2014a, MathWorks Inc., Natick, MA)
to allow batch analysis of treatment plans exported from the planning system in DICOM-RT
format. The software extracted plan parameters, including MLC leaf positions, jaw sizes, gantry
angle, MU and dose-rate, for each control point. Using these parameters both established and
novel plan complexity metrics were calculated for each plan.
2.3.1 Established Metrics
Table 2.1 Summary of initialisms of investigated established metrics.
MCSv Modulation complexity score for VMAT
LT Leaf travel
LTMCSv Leaf travel modulation complexity score
PI Plan irregularity
PM Plan modulation
CAS Cross axis score
CLS Closed leaf score
MAD Mean aperture displacement
MFA Mean field area
SASx Small aperture score with x mm threshold
PMU Plan normalised monitor units
In order to characterise plan deliverability MLC leaf travel (LT) metrics were investigated.
McNiven et al. first proposed the Modulation Complexity Score (MCS) for step-and-shoot
IMRT, this was later adapted for VMAT by Masi et al. [45, 46]. The MCS provides an
indication of the mobility of MLC leaves during delivery by considering two parameters: the
aperture area variability (AAV), the variation in control point area relative to the maximum
aperture defined by all control points; and the leaf sequence variability (LSV), the variation in
field shape between control points, considering the change in leaf position between adjacent
MLC leaves. All control points are weighted according to fractional MU of the beam. The
MCS decreases from unity (defined as single rectangular field) to zero with the addition of
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control points with smaller and more irregular apertures compared to maximum beam aperture.
Du et al. have developed a set of metrics to quantify different aspects of plan complexity
including plan aperture area (PA), aperture shape irregularity (PI), and plan modulation (PM)
[47]. A simplified physical interpretation of these metrics follows: PA is the MU weighted
average area of all MLC defined beam apertures in a plan, the PI describes the deviation of all
segment aperture shapes from a circle, and the beam modulation characterises the degree to
which the field is broken into small segments. Increased plan complexity can be characterised
with decreased PA, and increased PI and PM.
Crow et al. introduced a set of metrics which quantify parameters most likely to contribute
to inaccurate TPS dose calculation [48]. These include presence of small field segments, the
proportion of apertures centred off axis, and the presence of closed MLC leaves within the jaw
defined field. The cross axis score (CAS), closed leaf score (CLS), mean aperture displacement
(MAD), mean field area (MFA), and small aperture score (SAS) metrics were implemented in
this study.
2.3.2 Localised Complexity
Complexity metrics have historically been developed as a method of predicting gamma analysis
results for measurements of the entire field fluence, such as with a detector array, thus they
are calculated over the whole treatment field. The isocentre dose measurements in this study
represent dose to a point. Therefore, various complexity metrics were calculated within a
localised region about the point of interest with the goal to increase the sensitivity of the metric.
Figure 2.1 illustrates the ROI definition and naming formalism for this study; a 1 cm ROI
corresponds to a 1 × 1 cm2 square centred on the isocentre. The influence of ROI size variation
on metric correlation with point dose discrepancy has been investigated.
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Fig. 2.1 Definition of ROI used for localised complexity metric analysis as seen from beam’s
eye view. MLC leaves are clipped at main collimator jaw positions. The green contour defines
the air cavity for the CC04 CIRS Cube phantom insert. Both the 1 cm and 2 cm ROI are shown,
corresponding to 1 × 1 cm2 and 2 × 2 cm2 squares centred on isocentre respectively.
2.3.3 Additional Metrics
The perimeter defined by MLC leaves was summed for each control point and averaged over
the beam according to control point weight to give the mean field perimeter (MFP) metric. The
ratio MFPMFA will increase for irregular field shapes where an increased proportion of field area is
defined by MLC leaf edges.
The mean, variance, skewness, and kurtosis of the distribution of MLC leaf gap apertures
was investigated. A low mean leaf aperture indicates the presence of small fields which are
problematic for both the treatment dose calculation and the measurement. High variance and
skewness indicate irregularly shaped fields. A high kurtosis indicates the presence of outliers in
MLC aperture. These 4 distribution moments were also calculated for the dose rate distribution.
The blocked fraction (BF) is defined as the fractional area within an ROI about the isocentre
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shielded with MLC leaves or collimator jaws. The BF varies from 0, where no MLC leaves are
within the ROI, to unity in the case of a completely blocked region.
2.4 Dosimeters
For all measurements in this study, each detector was paired with the same PTW UNIDOS E
T10009 (PTW-Frieburg, Germany) electrometer. Figure 2.2 shows the detectors investigated in
this study.
Fig. 2.2 Detectors investigated in this study, from top to bottom: CC01, CC04, EFD3G, PFD3G,
and microDiamond.
2.4.1 Ionisation Chambers
Two ionisation chambers were investigated, the IBA CC01 and CC04 compact chambers (IBA
Dosimetry GmbH, Schwarzenbruck, Germany). The active volumes of the chambers are 0.01
cm3 and 0.04 cm3 respectively. Both chambers have cavity length of 3.6 mm, with the CC01
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and CC04 having outer electrode inner diameter of 2 mm and 4 mm respectively. The outer
electrode for both chambers is constructed of Shonka (C-552) conductive plastic. See table 2.2
for a summary of the properties of each of the ionisation chambers.
Table 2.2 Summary properties of ionisation chambers used in this study.
Detector Central electrode Wall Thickness [mg/cm2] Approximate sensitivity [C/Gy]
IBA CC01 Steel 88 4×10−10
IBA CC04 Shonka (C-552) 70 1.10×10−9
2.4.2 Silicon Diodes
Two diodes have been used in this study, the IBA EFD3G and PFD3G. Both consist of a 2.1 ×
2.1 × 0.4 mm chip, with active detector diameter and thickness of 1.6 and 0.08 mm respectively.
Both diodes have a typical sensitivity of 100 nC/Gy. The PFD has an integrated energy filter
that reduces the over-response of the diode to low-energy scattered radiation, which is abundant
in large photon fields at depth. IBA states that the PFD is optimised for photon fields larger
than 10 × 10 cm2. IBA goes on to recommend the EFD for small photon fields less than 10 ×
10 cm2.
2.4.3 Synthetic Diamond
The PTW 60019 microDiamiond detector (PTW-Frieburg, Germany) is a commercialisation of
the SCDD operating in the Schottky barrier photodiode configuration [49]. Figure 2.3 shows
an X-ray image and geometrical sketch of microDiamond detector. The device consists of a
1 µm intrinsic diamond film sandwiched between a 3 x 3 x 0.3 mm3 diamond plate and the
2.2 mm diameter Al contact, encased in a polystyrene and epoxy housing of 7 mm diameter.
This results in an active surface area of 2.2 mm in diameter and 1.0 µm thick active volume
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thickness, situated 1 mm below the top of the housing. For this study the detector was oriented
perpendicular to the beam and operated in photovoltaic mode.
2.5 Point Dose Measurements
2.5.1 Phantom
Point dose measurements were made using a CIRS Model 009 Cube 20 phantom (CIRS,
Norfolk, VA, USA), shown in figure 2.4. The phantom is constructed from Plastic Water DT,
with physical density of 1.039 g cm−3 with an electron density of 3.345×1023 cm−3, for 6
MV beams percent depth dose curves are within 0.5% of water [51]. Custom inserts were
manufactured to position each detector at the centre of the phantom. They were manufactured
in-house from Solid Water (Gammex rmi, Widdleton, WI, USA).
2.5.2 Preparation and Delivery
In order to compare calculated and delivered dose, each plan was recalculated on a CT image
dataset of the CIRS phantom. In every plan the isocentre was within a high-dose region in
the PTV, therefore the plan isocentre was set to the centre of the phantom. The CT couch
was overridden and an ROI based model of the Varian Exact IGRT couch was applied. Dose
calculation was performed with a 3 mm resolution dose grid using a collapsed cone convolution
algorithm. The origin of the dose grid was selected such that a calculation point would coincide
with the centre of the detector. The dose distribution was evaluated for each plan to ensure
the measurement point did not correspond to a high dose gradient region. For all plans, dose
heterogeneity across detector active volume was less than 5%, following AAPM TG 120
recommendations [19].
The treatment couch longitudinal and lateral positions were kept constant between measurement
sessions to ensure accurate and repeatable results. The top surface of the phantom was posi-
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tioned 90 cm from the photon source (90 cm SSD) using calibrated front pointers. Positioning
of the phantom on the treatment couch was achieved by aligning the linac optical field with
reference marks on the phantom. The custom inserts positioned the detector effective point of
measurement along its central axis at the isocentre (10 cm deep).
Once the phantom and dosimeter were in position, a reference field was delivered to compensate
for machine output fluctuations and allow conversion of raw chamber reading to absolute dose
in Gy. The reference field was a 6 MV photon beam of 100 MU, with field-size of 4 × 4 cm2
for the EFD and 10 × 10 cm2 for all other detectors. The smaller reference field for EFD was
chosen as unshielded diodes are known to over-respond to the low-energy scattered photons
present in large fields. The reference field was delivered regularly throughout the coarse of
each measurement session to ensure consistency of linac output. Each treatment plan was then
delivered without interruption.
At Auckland City Hospital linacs are calibrated to deliver 1 cGy/MU to the isocentre at depth
of dose maximum, dmax. Therefore for each plan, the ratio of raw electrometer reading to that
of the reference beam was multiplied by a tissue maximum ratio (TMR) (and relative output








TMR(10 x 10 cm2, 10 cm) ROF(4 x 4 cm2, 10 cm) (2.2)
2.5.3 Point Dose Repeatability
In order to quantify the repeatability of point dose measurements, 10 plans were selected to
be remeasured in two additional measurement sessions. Each plan was measured once per
measurement session, for a total of three measurements per plan per detector. A one-way
ANOVA with repeated measures model was used for each detector in order to estimate the
2.5 Point Dose Measurements 29
between-sessions standard deviation. An estimation of the coefficient of repeatability (COR)
can be calculated using equation 2.3. The absolute difference between two measurements on
a subject should differ by no more than this value on 95% of occasions [52]. Bland-Altman
analysis of the results, following the framework outlined by Bartlett and Frost, was undertaken
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Fig. 2.3 X-ray image and geometrical sketch of microDiamond detector, reproduced from
Marinelli et al. 2016 [50].
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Fig. 2.4 CIRS Model 009 Cube 20 with CC04 chamber positioned at centre of the phantom.




3.1 Point Dose Results
3.1.1 Repeatability Study
In order to quantify the repeatability of point dose measurements, 10 plans were selected to
be remeasured in two additional measurement sessions. Each plan was measured once per
measurement session, for a total of three measurements per plan per detector. A summary
of repeatability results are shown in table 3.1. The between-sessions standard deviation for
each detector was estimated by fitting a repeated-measures ANOVA model. Sphericity was
not assumed and a Geisser-Greenhouse correction was used. An assumption of the ANOVA
model is that the standard deviation of measurement errors is consistent throughout the range
of ‘error-free’ values. This was verified using Bland-Altman analysis of results between
measurement sessions. This qualitatively displays paired differences against population mean,
refer to appendices B.1 to B.4. The between-sessions standard deviation was less than 0.5% of
the mean measured dose for all detectors excluding the photon diode. Figure 3.1 shows the
coefficients of repeatability for each detector as a percentage of mean measured dose. The
CC01, CC04, and EFD were the most repeatable, with coefficients of repeatability of 0.29%,
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0.4%, 0.55% respectively. The coefficients of repeatability for the microDiamond and PFD
were both above 1% (1.30% and 1.53% respectively).
Table 3.1 Repeatability analysis of remeasured plans using all five detectors.
Detector Between-sessions SD (mGy) Coefficient of Repeatability (mGy) 95% CI
CC01 2.5 6.9 5.2 - 10
CC04 3.3 9.3 7.0 - 14
EFD 4.6 12.8 9.7 - 19
PFD 12.9 35.9 27 - 53
microDiamond 11.0 30.5 23 - 45
Abbreviations: SD, standard deviation; CI, confidence interval.
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Fig. 3.1 Repeatability Coefficients with corresponding 95% confidence intervals for each
detector obtained over 3 measurement sessions, expressed as percentage of mean measured
dose.
3.1.2 Treatment Planning System Calculation
Isocentre dose was calculated in Pinnacle (with both 4 degree and 2 degree control point spacing)
and RayStation. Post-hoc analysis of a repeated measures ANOVA with Greenhouse-Geisser
correction, using Tukey’s multiple comparison method was undertaken to investigate pairwise
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difference between mean isocentre doses calculated with each beam model. A statistically
significant difference in mean isocentre dose for all calculation techniques (P < 0.0001 ) at the
95% confidence level was found.
3.1.3 Dosimeters
Pairwise differences between dosimeter measurements were evaluated using Tukey’s multiple
comparison method with the results of a repeated measures ANOVA using Greenhouse-Geisser
correction. The results are presented in table 3.2. Statistically significant differences in mean
dose were found between the CC04 chamber and all other detectors.
Table 3.2 Summary of Tukey’s multiple comparison of mean detector measurement results.
Bold font indicates statistically significant correlations at 95% confidence level.
Mean Difference P Value
CC01 vs. CC04 -0.0141 <0.0001
CC01 vs. EFD -0.0026 0.9303
CC01 vs. PFD 0.0065 0.2297
CC01 vs. microDiamond 0.0033 0.5898
CC04 vs. EFD 0.0115 0.0214
CC04 vs. PFD 0.0206 <0.0001
CC04 vs. microDiamond 0.0174 <0.0001
EFD vs. PFD 0.0090 0.0689
EFD vs. microDiamond 0.0058 0.0109
PFD vs. microDiamond -0.0032 0.8446
Agreement between measured and calculated isocentre point doses can be seen in figure 3.2. A
summary of mean point dose agreement can be found in table 3.3. All detectors, aside from the
PFD, achieve agreement better than 0.5% for both 2 degree and 4 degree gantry angle spacing
in Pinnacle. The EFD displayed the best agreement with Pinnacle; -0.225% and -0.054% for 4
and 2 degree gantry spacing respectively. The disagreement between measured and calculated
dose is statistically significant (P < 0.05) for all detectors apart from the CC04 and EFD for 4
degree gantry spacing. When 2 degree gantry spacing is used, only the CC01 and EFD have no
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statistically significant difference. There exists a systematic offset between RayStation dose
calculation results and measurement - disagreement is greater than 0.5% for all detectors.
Table 3.3 Summary of mean point dose discrepancy for each detector and TPS calculation
algorithm.
Mean Difference Measured - Calculated (%)
CC01 CC04 EFD PFD microDiamond
Pinnacle 4 degree GS -0.3417 0.240 -0.225 -0.594 -0.463
Pinnacle 2 degree GS -0.170 0.413 -0.054 -0.423 -0.292
RayStation -1.175 -0.598 -1.059 -1.425 -1.295
3.2 Plan Complexity
Metrics have been calculated in order to quantify plan complexity and investigate the rela-
tionship between plan parameters and point dose discrepancy. Complexity metrics previously
published in the literature and novel metrics have been calculated for each treatment plan. Pear-
sons’s correlation analysis between complexity metrics and point dose measurement results for
the range of detectors has been undertaken to identify the most significantly correlated metrics
[54]. Unless otherwise stated, the following correlation analysis has been undertaken for point
dose measurement results using the Pinnacle beam model with 2 degree gantry spacing. This is
the ‘gold standard’ calculation method for this study as the plans were originally optimised in
Pinnacle and 2 degree gantry spacing has been shown to increase calculation accuracy.
3.2.1 Established Metrics
Results for established complexity metrics for prostate plans are summarised in the descriptive
statistics shown in table 3.4. A summary of correlation analysis between established complexity
metrics is presented in table 3.5. Only moderate strength correlations exist between plan MU
and other metrics, but strong correlations were found for the PMU. The PM metric is very
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strongly correlated with MCSv derived metrics, with correlation coefficients of r =−0.953 and
r = 0.917 for MCSv and LTMCSv respectively. Strong correlations exist between CAS, CLS,
and MAD metrics and PI. The MFA metric is most strongly correlated with the SAS metrics.
Table 3.4 Summary established complexity metric results for prostate VMAT plans.
Minimum Maximum Mean ( ± SD) 95% CI
LT 195 564 410 ± 69.6 390 - 431
MCSv 0.287 0.499 0.376 ± 0.0445 0.363 - 0.389
LTMCSv 0.13 0.397 0.233 ± 0.0539 0.217 - 0.249
PI 2.34 7.44 4.25 ± 0.888 3.99 - 4.52
PM 0.236 0.576 0.443 ± 0.0674 0.423 - 0.464
CAS 0.161 0.595 0.411 ± 0.928 0.384 - 0.439
CLS 0.0171 0.169 0.0885 ± 0.0375 0.0773 - 0.0998
MAD 5.11 15.6 11.3 ± 2.38 10.5 - 12
MFA 1880 4810 2930 ± 555 2760 - 3090
SAS10 0.0364 0.156 0.0904 ± 0.0256 0.0827 - 0.0981
SAS20 0.108 0.351 0.238 ± 0.0491 0.223 - 0.253
MU 281 749 532 ± 73.2 510 - 554
PMU 427 619 526 ± 44.5 512 - 539
Abbreviations: SD, standard deviation; CI, confidence interval.
Table 3.5 Pearson correlation coefficients for relationships between established metrics.
LT MCSv LTMCSv PI PM CAS CLS MAD MFA SAS10 SAS20 MU PMU
LT -0.714 -0.787 0.600 0.765 0.601 0.338 0.758 0.061 0.019 0.206 0.244 0.551
MCSv -0.714 0.925 -0.679 -0.953 -0.840 -0.541 -0.744 0.522 -0.397 -0.619 -0.326 -0.587
LTMCSv -0.787 0.925 -0.651 -0.917 -0.788 -0.506 -0.762 0.338 -0.334 -0.510 -0.416 -0.623
PI 0.600 -0.679 -0.651 0.804 0.843 0.717 0.719 -0.236 0.541 0.607 0.350 0.663
PM 0.765 -0.953 -0.917 0.804 0.902 0.635 0.859 -0.346 0.416 0.576 0.308 0.656
CAS 0.601 -0.840 -0.788 0.843 0.902 0.825 0.841 -0.485 0.511 0.629 0.255 0.620
CLS 0.338 -0.541 -0.506 0.717 0.635 0.825 0.598 -0.415 0.376 0.371 0.109 0.367
MAD 0.758 -0.744 -0.762 0.719 0.859 0.841 0.598 -0.083 0.149 0.279 0.059 0.484
MFA 0.061 0.522 0.338 -0.236 -0.346 -0.485 -0.415 -0.083 -0.551 -0.686 -0.134 -0.182
SAS10 0.019 -0.397 -0.334 0.541 0.416 0.511 0.376 0.149 -0.551 0.884 0.475 0.469
SAS20 0.206 -0.619 -0.510 0.607 0.576 0.629 0.371 0.279 -0.686 0.884 0.424 0.571
MU 0.244 -0.326 -0.416 0.350 0.308 0.255 0.109 0.059 -0.134 0.475 0.424 0.581
PMU 0.551 -0.587 -0.623 0.663 0.656 0.620 0.367 0.484 -0.182 0.469 0.571 0.581
Table 3.6 gives a summary of the statistical significance of linear correlations between es-
tablished complexity metrics and point dose discrepancy results for the range of detectors.
As demonstrated in table 3.6 multiple significant correlations exist for both of the ionisation
chambers, none for the diodes, and only a single significant correlation with plan MU for the
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microDiamond detector. There is a weak correlation for the MCSv metric with CC04 measured
results, indicating dose discrepancy increases for decreasing MCSv (an increase in modulation).
Three metrics are significantly correlated with both ionisation chambers (CC01 and CC04): PI,
CLS, and MAD. An increase in any of these metrics is correlated with increased point dose
discrepancy, as displayed in figure 3.3(a-c). In each case the CC04 measurements have greater
Pearson correlation coefficients compared to the CC01 measurements: 0.407 vs. 0.373, 0.392
vs. 0.314, and 0.386 vs. 0.350 for PI, CLS, and MAD respectively. A statistically significant
correlation exists for MCSv, PM, and CAS for the CC04 point dose measurements only.
Table 3.6 Correlations between point dose discrepancy and established complexity metrics for
Pinnacle dose calculation (2 degree gantry spacing). Bold font indicates statistically significant
correlations at 95% confidence level.
CC01 CC04 EFD PFD microDiamond
r p value r p value r p value r p value r p value
LT 0.2176 0.151 0.231 0.1268 -0.1218 0.4254 -0.2008 0.186 -0.2438 0.1066
MCSv -0.1755 0.2489 -0.2982 0.0466 0.2471 0.1017 0.03243 0.8325 0.1608 0.2914
LTMCSv -0.1747 0.2512 -0.2485 0.0997 0.2476 0.101 0.08355 0.5853 0.2256 0.1362
PI 0.3728 0.0117 0.407 0.0055 0.08411 0.5828 0.0566 0.7119 0.04659 0.7612
PM 0.2512 0.096 0.3416 0.0217 -0.1493 0.3277 -0.04536 0.7673 -0.1247 0.4144
CAS 0.2593 0.0855 0.3653 0.0136 -0.06715 0.6612 0.0415 0.7866 -0.04256 0.7813
CLS 0.3136 0.0359 0.3916 0.0078 0.05404 0.7244 0.1624 0.2864 0.1862 0.2206
MAD 0.3502 0.0184 0.3863 0.0088 0.002154 0.9888 -0.03485 0.8202 -0.06075 0.6918
MFA 0.0444 0.7721 -0.1564 0.3048 0.2342 0.1215 -0.1891 0.2135 -0.08613 0.5737
SAS2 0.02304 0.8806 0.07516 0.6236 -0.2149 0.1564 0.1313 0.3898 -0.09208 0.5474
SAS5 -0.02585 0.8662 0.02629 0.8639 0.008204 0.9573 0.1578 0.3005 0.1055 0.4904
SAS10 -0.09306 0.5432 0.01025 0.9467 -0.04438 0.7722 0.03654 0.8116 0.01614 0.9162
SAS20 -0.1276 0.4036 0.006724 0.965 -0.1121 0.4635 0.04279 0.7802 -0.08335 0.5862
MU -0.02901 0.85 -0.01424 0.926 -0.2631 0.0808 -0.09812 0.5214 -0.296 0.0483
PMU 0.0939 0.5395 0.1132 0.4593 -0.1316 0.3889 -0.06445 0.674 -0.1654 0.2777
3.2.2 Region of interest
No significant correlations exist for any detector for the original LTMCSv metric. But when
the metric is evaluated within a region of 1 cm to 4 cm about the isocentre, a statistically
significant correlation is observed for the CC04 detector. Evaluation of the metric for the 1 cm
ROI produces the strongest correlation coefficient (r =−0.358).
Evaluation of LT across the entire treatment field also produces no statistically significant
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correlations. Calculation of the metric within regions of 1 cm to 3 cm about the measurement
point leads to statistically significant correlations for the EFD detector. With a 1 cm ROI a
correlation coefficient of moderate strength (r = −0.400) is produced. Correlation strength
decreases with increasing ROI dimensions.
Evaluation of the CAS metric within regions of 2 cm to 9 cm about the measurement point
results in increased correlation strength compared to the global evaluation for the CC04 detector.
The most significant correlation occurs with ROI dimension of 9 cm which gives r = 0.395
(global evaluation correlation coefficient r = 0.365).
Calculation of the SAS metrics for regions of 1 cm and 2 cm about the measurement point
result in strong correlations with ionisation chamber measurements. For example, the SAS20
with a 1 cm ROI gives correlation coefficients of r =−0.517 (CC01) and r =−0.455 (CC04),
but the utility of such strict conditions on the metric is limited; only 3 of 45 plans achieved a
non-zero value for this metric. Decreasing the threshold value from 20 mm further reduces the
number of non-zero scores.
3.2.3 Additional Metrics
No statistically significant correlations were found for either the MFP or the ratio MFPMFA for
any detector. Table 3.7 summarises correlation results for MLC aperture distribution moment
analysis. Statistically significant correlations exist for the EFD measured point doses with skew-
ness and kurtosis, giving correlation coefficients of r =−0.348 and r =−0.342 respectively.
Identical analysis of dose rate distribution yielded no statistically significant correlations.
Only the CC04 detector measurements resulted in statistically significant correlations with
the blocked fraction metric, as seen in table 3.8. Significant correlations occurred for ROI
dimensions of 1 cm to 6 cm. The strongest correlation was found for a ROI of 4 cm, with a
correlation coefficient of r = 0.378.
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Table 3.7 Correlations between point dose discrepancy and MLC aperture distribution moments
for Pinnacle dose calculation (2 degree gantry spacing). Bold font indicates statistically
significant correlations at 95% confidence level.
CC01 CC04 EFD PFD microDiamond
r p value r p value r p value r p value r p value
Mean 0.0444 0.7721 -0.1564 0.3048 0.2342 0.1215 -0.1891 0.2135 -0.08613 0.5737
Variance 0.04172 0.7855 -0.1518 0.3196 0.1738 0.2536 -0.1989 0.1902 -0.1143 0.4547
Skewness -0.08654 0.5719 0.08205 0.5921 -0.3487 0.0189 0.1335 0.3818 0.004486 0.9767
Kurtosis -0.06545 0.6693 0.1028 0.5015 -0.3419 0.0215 0.123 0.4208 0.01036 0.9462
Table 3.8 Correlations between point dose discrepancy and blocked fraction metric, calculated
over 1 cm to 8 cm ROI, for Pinnacle dose calculation (2 degree gantry spacing). Bold font
indicates statistically significant correlations at 95% confidence level.
CC01 CC04 EFD PFD microDiamond
ROI (cm) r p value r p value r p value r p value r p value
1 0.2445 0.1055 0.3504 0.0183 -0.1053 0.4912 0.005769 0.97 -0.09764 0.5234
2 0.2614 0.0829 0.3652 0.0136 -0.09723 0.5252 0.01924 0.9002 -0.09899 0.5177
3 0.2728 0.0698 0.376 0.0109 -0.09018 0.5558 0.01693 0.9121 -0.09507 0.5345
4 0.2672 0.076 0.3778 0.0105 -0.1057 0.4897 0.01913 0.9008 -0.08075 0.598
5 0.225 0.1374 0.3515 0.0179 -0.1265 0.4078 0.02201 0.8859 -0.07157 0.6403
6 0.1607 0.2916 0.3097 0.0384 -0.139 0.3625 0.09769 0.5232 -0.00926 0.9518
7 0.08221 0.5914 0.2654 0.078 -0.196 0.1969 0.1729 0.256 0.04258 0.7812
8 0.01518 0.9212 0.2118 0.1624 -0.2226 0.1416 0.1959 0.1972 0.06801 0.6571
3.2.4 Influence of Calculation Method
The choice of algorithm has a significant influence on calculated dose, as discussed in section
3.1.2. This influences the relationship between point dose discrepancy and complexity met-
rics. When 4 degree gantry spacing is used for the Pinnacle dose calculation, no established
metrics investigated in this study produce statistically significant correlations. Table 3.9 shows
correlation significance results when RayStation is used to calculate dose. The only metric
with statistically significant correlations is the CLS with Pearson coefficients of r = 0.336 and
r = 0.382, for the CC01 and CC04 ionisation chambers respectively.
Doses were also calculated using an older version of the department’s Pinnacle beam model that
has been modelled against less reliable small field measurements. Table 3.10 shows correlations
found for 2 degree gantry spacing calculation. There exist statistically significant correlations
between point dose discrepancy for small field related metrics (MFA, SAS10, and SAS20) that
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Table 3.9 Correlations between point dose discrepancy and established complexity metrics for
RayStation dose calculation. Bold font indicates statistically significant correlations at 95%
confidence level.
CC01 CC04 EFD PFD microDiamond
r p value r p value r p value r p value r p value
LT 0.148 0.3319 0.151 0.322 -0.1471 0.335 -0.153 0.3158 -0.1898 0.2117
MCSv -0.1114 0.4662 -0.2133 0.1594 0.2639 0.0799 0.00701 0.9635 0.1544 0.3113
LTMCSv -0.07789 0.611 -0.1393 0.3616 0.2826 0.06 0.06468 0.6729 0.2253 0.1368
PI 0.2385 0.1146 0.2542 0.092 0.0162 0.9159 0.06207 0.6854 0.04723 0.758
PM 0.2016 0.1841 0.2688 0.0742 -0.161 0.2906 0.008635 0.9551 -0.07892 0.6063
CAS 0.2076 0.1712 0.2881 0.055 -0.0848 0.5797 0.1192 0.4353 0.02231 0.8843
CLS 0.3357 0.0242 0.3822 0.0096 0.07217 0.6376 0.2087 0.1689 0.2303 0.1281
MAD 0.1962 0.1964 0.2166 0.153 -0.07326 0.6325 -0.02347 0.8784 -0.05282 0.7304
MFA 0.1262 0.4089 -0.06049 0.693 0.2686 0.0745 -0.08691 0.5703 0.05069 0.7409
SAS2 0.07678 0.6162 0.1173 0.4428 -0.1718 0.2592 0.2106 0.1649 -0.05665 0.7117
SAS5 -0.07992 0.6018 -0.02804 0.8549 -0.0232 0.8798 0.09504 0.5346 0.02083 0.892
SAS10 -0.08943 0.5591 0.007695 0.96 -0.04293 0.7795 0.04415 0.7734 0.01971 0.8978
SAS20 -0.1682 0.2693 -0.038 0.8043 -0.1322 0.3866 0.05777 0.7062 -0.09095 0.5524
MU 0.09762 0.5235 0.1032 0.4998 -0.1786 0.2405 0.03477 0.8206 -0.1819 0.2319
PMU 0.1238 0.4179 0.1328 0.3845 -0.1053 0.4912 -0.00804 0.9582 -0.118 0.4401
do not exist for the new Pinnacle beam model calculation. These correlations are seen across
all detectors excluding the PFD for MFA. The strongest correlation is for the CC01 measured
dose discrepancy with a correlation coefficient of r = 0.471, as seen in figure 3.4. The original
beam model is now known to have been based on old small field beam data measured with less
suitable small field detectors. This suggests that complexity metric correlation analysis may be
useful in identifying deficiencies in beam modelling.
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Table 3.10 Correlations between point dose discrepancy and established complexity metrics
for original Pinnacle model dose calculation (2 degree gantry spacing). Bold font indicates
statistically significant correlations at 95% confidence level.
CC01 CC04 EFD PFD microDiamond
r p value r p value r p value r p value r p value
LT 0.0158 0.9179 0.0308 0.8406 -0.19 0.2102 -0.212 0.162 -0.252 0.095
MCSv 0.2368 0.1173 0.1396 0.3606 0.414 0.005 0.2263 0.1349 0.375 0.011
LTMCSv 0.151 0.3221 0.0923 0.5466 0.367 0.013 0.2021 0.1831 0.358 0.016
PI -0.028 0.8527 0.0038 0.9802 -0.117 0.4459 -0.1 0.5115 -0.124 0.4162
PM -0.119 0.4363 -0.043 0.7782 -0.3 0.043 -0.187 0.2195 -0.28 0.0629
CAS -0.158 0.2989 -0.071 0.6447 -0.261 0.083 -0.117 0.445 -0.219 0.1481
CLS 0.0047 0.9754 0.077 0.6151 -0.096 0.5302 -0.002 0.9872 0.005 0.9741
MAD 0.0466 0.7614 0.0845 0.5811 -0.133 0.3855 -0.104 0.4979 -0.136 0.3731
MFA 0.472 0.001 0.321 0.032 0.434 0.003 0.16 0.2936 0.3 0.045
SAS2 -0.154 0.3125 -0.116 0.4474 -0.272 0.0708 0.0428 0.78 -0.207 0.1722
SAS5 -0.248 0.1008 -0.216 0.1548 -0.119 0.4361 -0.032 0.8323 -0.107 0.4861
SAS10 -0.34 0.023 -0.266 0.0774 -0.18 0.2358 -0.131 0.3919 -0.164 0.2805
SAS20 -0.47 0.001 -0.38 0.011 -0.292 0.0517 -0.159 0.2971 -0.31 0.04
MU -0.014 0.9281 -0.002 0.9916 -0.211 0.1646 -0.033 0.8271 -0.235 0.1201
PMU -0.135 0.3765 -0.125 0.4152 -0.226 0.1359 -0.167 0.2736 -0.278 0.0643
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Fig. 3.2 Mean point dose agreement for each calculation method and detector with correspond-
ing standard deviations.
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Fig. 3.3 Complexity metrics with statistically significant linear relationships with point dose
discrepancy for both CC01 (filled data points) and CC04 (open data points) ionisation chambers.
a Plan Irregularity (PI), b Closed Leaf Score (CLS), c Mean Aperture Displacement (MAD).
Dose calculated in Pinnacle using 2 degree gantry spacing.
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Fig. 3.4 Difference in correlation of small field complexity metrics with point dose discrepancy
for both original Pinnacle beam model (filled data points) and new Pinnacle beam model (open
data points) for CC01 ionisation chamber. a Mean Field Area (MFA) and b Small Aperture




The combination of point dose measurements and gamma analysis of dose plane measure-
ments has been shown to provide the highest sensitivity and specificity in detecting significant
dosimetric errors in IMRT [25]. With the shift towards IMRT and VMAT away from 3DCRT,
the number of plans requiring verification measurements is unsustainable with current patient
specific QA methods. The primary motivation for this project is to identify key plan parameters
and understand how they influence point dose discrepancy results in order to optimise the
patient specific QA procedure for VMAT treatments.
Ultimately, point dose discrepancy results depend on the accuracy of the measurement and
dose calculation. Detector characteristics such as active volume size, energy response, and dose
rate response will all influence measured dose. Suitable detector choice is essential to ensure
reliable patient specific QA results. In this study five detectors have been investigated.
Treatment planning system dose calculation limitations must be known and evaluated. Calcu-
lated dose depends on the choice of calculation algorithm and parameters, such as gantry angle
spacing. In this study, treatment plan doses have been calculated in Pinnacle with both 4 degree
gantry spacing and interpolated 2 degree gantry spacing. Recalculation of dose in RayStation
has also been undertaken. Both measurement and calculation results will be discussed in the
first and second sections of this chapter.
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The ability to predict which treatment plans are likely to fail patient specific QA a priori
would reduce physics workload and decrease the impact of any delays due to re-planning of
undeliverable treatments. Theoretically this could be achieved with plan complexity metrics
which are strongly correlated with plan dosimetric accuracy. Little work has been done to
identify complexity metrics which correlate with point dose discrepancy results, with most
papers instead focusing on gamma analysis results. The suitability of a range of established
complexity metrics and novel ROI based complexity metrics has been investigated. Discussion
of these metrics will be undertaken in the third section of this chapter.
4.1 Treatment Planning System Calculation
The following section discusses the influence of planning system calculation technique on dose
calculation results. The two treatment planning systems used for VMAT at Auckland City
Hospital; Pinnacle and RayStation have been evaluated. In addition, the effect of control point
gantry angle spacing for calculated dose is evaluated for the Pinnacle treatment planning system.
The correlation of plan complexity metrics and point dose discrepancy has been undertaken in
section 3.2.4 and is discussed further in section 4.3.3.
4.1.1 Pinnacle
All of the treatment plans investigated in this study were created in Pinnacle using SmartArc.
Plans were optimised and the final dose was calculated using a final gantry spacing of 4 degrees
per control point. It has been shown that decreasing the gantry spacing angle leads to increased
agreement of calculated field fluence and fluence measured with detector arrays [55]. The
choice of 4 degree per control point gantry spacing is used clinically at Auckland City Hospital
as a trade off between calculation time and dosimetric accuracy.
Pinnacle allows the interpolation of control points so that plans originally optimised with 4
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degree gantry spacing can be calculated with 2 degree gantry spacing. Table 3.3 shows the
use of interpolated control points increases the agreement between calculated and measured
point doses for all detectors other than the CC04. As discussed in section 2.2.1, Pinnacle
approximates VMAT dose delivery as the sum of contributions from static beams at each
control point. The agreement between calculation and delivered dose will therefore depend on
the degree of leaf modulation between adjacent control points. These results show that moving
from the relatively coarse 4 degree gantry spacing to interpolated 2 degree spacing leads to an
increase in agreement between calculated and measured dose.
4.1.2 RayStation
A systematic offset between the dose calculated in RayStation measurements result can also be
see in table 3.3. All detectors measure point doses lower than those produced by the RayStation
calculation. These results are in line with the old Pinnacle beam model investigated in section
3.2.4. As with the old Pinnacle beam model, the RayStation beam model is based on beam data
measured using detectors now known to be less suitable for small field dosimetry. Therefore the
evaluation of detector performance on the basis of absolute agreement between measurement
results and the RayStation calculation has not been undertaken in this study.
4.2 Dosimeters
In this section, the results of point dose measurements are discussed, highlighting the measure-
ment differences between each detector. VMAT treatments produce challenging measurement
conditions for detectors, including dynamically changing small fields, and varying dose rates.
The energy spectrum and fluence of the beam incident on the detector is variable in a VMAT
delivery. Interaction of the beam with MLC leaves positioned about the detector will shift the
energy spectrum of the beam reaching the detector when compared to open field conditions.
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Charged particle equilibrium cannot be assumed for the whole measurement and perturbations
of charged particle fluence by the detector will influence the measured dose. The magnitude of
these perturbations is dependent on the geometry of the detector and the material make up of
the device. Along with the desirable dosimetric qualities of stability, linearity, dose rate and
energy independence, angular independence, and fast response; the ideal detector for VMAT
measurements will have a small active volume and be constructed of water equivalent material
to reduce the volume averaging effect and fluence perturbation respectively.
It follows that detector choice will influence measurement results significantly, as seen in
section 3.1.3. The following sections will discuss the suitability of each detector for use as a
point dosimeter in VMAT plan verification measurements.
4.2.1 Repeatability
A random selection of 10 treatment plans were measured three times for each detector over
three measurement sessions (15 measurements per plan total, each plan was measured once per
session) in order to evaluate the repeatability of point dose measurements for VMAT. Fitting of
a repeated measures ANOVA model allowed the estimation of the coefficient of repeatability
for each detector. The coefficient of repeatability (also known as the smallest real difference)
quantifies the absolute measurement error in the same units as the measurement itself. It is the
value below which the absolute differences between two measurements would lie with 95%
probability [52]. It can be visualised as the 95% limits of agreement used in Bland-Altman
analysis that envelope 95% of the differences between repeated measurements on the same
subjects.
Three of the five detectors investigated in this study were found to have coefficient of repeata-
bility less than 5 mGy, see table 3.1. The 95% confidence intervals for correlation coefficients
overlap for the CC01, CC04 and EFD detectors. Further repeat measurements may allow for
sufficient statistical power to differentiate between these detectors, but as it stands all of these
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detectors have a coefficient of repeatability less than 0.55% of the mean measured dose. The
coefficient of repeatability for the PFD and microDiamond detectors was found to be more
than twice this value, at 12.9 mGy and 11.0 mGy respectively. Both ionisation chambers
achieved the greatest repeatability, with repeatability coefficient less than 0.5% when expressed
as percentage of mean measured value.
The repeatability study design assessed the practical repeatability of point dose measurements
which is comprised of delivery repeatability and set-up repeatability together. A recent study
investigated VMAT dose delivery reproducibility, and found a relative standard deviation of
< 0.1% between 10 consecutive deliveries [56]. This result suggests the bulk of repeatability
error can be attributed to set-up error. Care was taken to select treatment plans where the
measurement point was free of steep dose gradients, but there still exists a degree of dose inho-
mogeneity around the measurement points. To achieve repeatable measurements the position
of the detector sensitive volume must be reproducible between measurements sessions.
The smaller the sensitive volume of the detector the more sensitive the detector is to set up
errors. The microDiamond detector active volume is effectively a slice 1 µm thick when ori-
ented perpendicularly to the beam. The comparatively larger sensitive volumes of the ionisation
chambers provide a volume averaging effect which reduces the impact of small positional
offsets. This difference in sensitive volume size may explain why the microDiamond detector
coefficient of repeatability is approximately 3 times that of the CC04. The PFD achieved the
worst repeatability results, even though the active volume is identical in size to the EFD. The
presence of metallic shielding within the PFD encapsulation material may introduce perturba-
tion effects which renders the PFD unsuitable as a detector for VMAT point dose measurements.
This effect is discussed further in section 4.2.3.
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4.2.2 Ionisation Chambers
Table 3.3 summarises point dose discrepancy results for all detectors and calculation methods.
The CC01 chamber measured dose lower than calculated in each case, with the best agreement
of −0.170% for the 2 degree gantry spacing Pinnacle calculation. This contrasts with the CC04
measurements which are higher than calculated for both Pinnacle calculations.
Small volume ionisation chambers such as the CC04 are the most commonly used detectors for
VMAT and IMRT point dose measurements. Cylindrical ionisation chambers have been well
characterised in the literature and have been found to have good stability, linear response to
dose, small directional dependence, and insensitivity to beam quality [19]. The most significant
challenge for the use of ionisation chambers in VMAT measurements is achieving sufficient
spatial resolution. All ionisation chambers produce some degree of volume averaging by virtue
of charge collection throughout the active volume of the chamber. Volume averaging has been
shown to lead to an under-estimation of dose for output measurements in small fields [57]. To
the contrary, in this study the CC04 measurements were higher than calculated. In addition,
there exists a statistically significant difference between the CC04 measurements and those for
all other detectors, as seen in table 3.2.
A secondary consequence of volume averaging is the blurring of the dose distribution of rapidly
spatially varying fields. Modelling the ionisation chamber active volume in the treatment
planning system allows the average dose within the volume to be calculated. This method
accounts for the volume averaging of the chamber and may lead to better agreement between
with measured dose.
The CC01 chamber achieves greater spacial resolution when compared to the CC04 due to
a smaller active volume. The central electrode of the CC01 chamber is constructed of steel
to increase the ionisation signal, resulting in the sensitivity of the CC01 being approximately
36% of the CC04 with only 25% of the active volume size. Photoelectric interactions within
the steel electrode cause the CC01 to over-respond to Compton scatter present in large fields
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[58]. Therefore a smaller 4 × 4 cm2 reference field for the relative dose calculation may be
more optimal than 10 × 10 cm2 to avoid underestimation of dose. This over-response in the
reference field may account for the lower response of the CC01 chamber when compared to the
CC04 which does not over-respond for a 10 × 10 cm2 field.
Both the CC01 and CC04 chambers are suitable detectors for point dose measurements in
VMAT due to their good repeatability and agreement with treatment planning system dose
calculation.
4.2.3 Silicon Diodes
The relative efficiency of per unit volume for silicon diodes is on the order of 104 times
greater than air ionisation chambers. This allows the construction of diode detectors with
very small active volumes while still maintaining high sensitivity. Both diodes investigated in
this study have active volumes approximately 1/250th of the CC04 ionisation chamber, but
achieve approximately 100 times greater sensitivity. As mentioned earlier, small active volume
size reduces volume averaging and is therefore an attractive property for VMAT point dose
measurement devices. Traditionally, point dose measurements have been made in regions of
homogeneous dose to reduce the impact of volume averaging, but identification of these regions
can prove to be difficult where steep dose gradients are required to achieve highly conformal
dose distributions. The use of small active volume detectors would allow the measurement
of point doses in high dose gradient regions. Kairn et al. have evaluated the suitability of
diodes for VMAT QA and found agreement within 2% between diode and ionisation chamber
measurements [59].
Table 3.3 summarises the mean point dose discrepancies for each detector and treatment
planning system. The EFD achieved the best agreement with dose calculated in Pinnacle for
both 4 degree and 2 degree gantry spacing, while the PFD had the worst agreement of any
detector with all treatment planning system calculations investigated. As discussed in section
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4.2.1, the PFD also has the worst repeatability results of the detectors tested in this study.
Conversely, there exists no statistically significant difference for EFD repeatability results and
the ionisation chambers.
The construction of both diodes is identical aside from the inclusion of shielding to filter low-
energy photons in the PFD. Silicon diode detectors exhibit a higher sensitivity to low-energy
photons as a result of the higher atomic number of silicon compared to water. Leading to an
over-response in large field sizes, as the proportion of low-energy scattered photons to primary
beam photons increases with field size. The addition of shielding within the diode encapsulation
is the traditional method to overcome the low-energy over-response. High Z materials are
typically used for shielding due to their high photoelectric cross-section. Tungsten powder is
used in the encapsulation of the PFD [60]. The presence of metallic shielding within the diode
encapsulation is known to be undesirable in small fields and leads to unwanted attenuation of
the low-energy spectrum and an over-response from electron scattering [61]. The manufacturer
states that the PFD is optimised for large photon fields greater than 10 × 10 cm2 [62]. Therefore
the PFD may be unsuitable for VMAT point dose measurements, where small field segments are
common. The magnitude of variation of detector response for beams entering perpendicularly
to the diode axis is approximately 3% for the EFD [63]. Increased directional dependence has
been observed for shielded diodes when compared to unshielded diodes [64]. This increased
directional dependence may contribute to the poor agreement between measured and calculated
point doses using the PFD.
The measurement of a 10 × 10 cm2 reference field for dose calculation is unsuitable for the EFD
due to the established over-response. A 4 × 4 cm2 reference field was selected instead. Kairn
et al. recommend that unshielded diodes should not be used for output factor measurements
in fields larger than 6 × 6 cm2 [65]. The close agreement between EFD measurements and
treatment planning system calculations suggest that the over-response of the unshielded diode
does not have a significant impact for prostate VMAT plans. The mean jaw defined equivalent
4.2 Dosimeters 55
square field size for all plans was 9.1 × 9.1 cm2. But when the MLC is taken into account, the
average mean field area becomes 29 cm2, which corresponds to an equivalent square field of
5.4 × cm2. Although this analysis does not take into account the non-uniform shape of MLC
defined fields, therefore the equivalent square field approximation may no longer be strictly
valid; the results aid conceptualisation of field size.
4.2.4 Synthetic Diamond
Like silicon diodes, SCD detectors exhibit high radiation sensitivity and small active volume
size. Unlike silicon diodes, SCD detectors are nearly tissue equivalent in terms of atomic
composition, leading to very similar mass energy absorption coefficients for both water and
synthetic diamond. Energy dependence for clinical radiation beams is not significant as the
SCD is approximately radiologically equivalent to tissue. SCD detectors also exhibit superior
radiation hardness, better temperature stability, and lower leakage currents when compared to
silicon diodes.
The above mentioned properties have motivated the dosimetric evaluation of SCD detectors
for use in IMRT/VMAT dosimetry. Zani et al. found good agreement between the microDi-
amond detector and the A1SL ionisation chamber for the measurement of small field output
factors, angular dependence of the detector, and the measurement of dose profiles for VMAT
treatments of pulmonary disease [66]. Almaviva et al. concluded that for prostate IMRT the
microDiamond detector temporal dose response was comparable to small volume ionisation
chambers and point dose measurements agree within 2% between the detectors [41]. The point
dose measurement results presented in section 3.1.3 are in line with these studies. Similar to
all other detectors, aside from the CC04, the microDiamond detector measured point doses
lower than calculated for all calculation methods. Measured dose discrepancy was −0.463%
and −0.292% respectively for 4 and 2 degree gantry spacing in Pinnacle, demonstrating better
agreement than the PFD but worse than the CC01. Like the CC01, a smaller reference field
56 Discussion
may have been more suitable for dose calculation; although the magnitude of improvement
would be slight due to the near water equivalence of the detector.
Only the PFD detector achieved worse repeatability than the microDiamond detector, shown
in table 3.1. The coefficient of repeatability was calculated to be 1.3% of the measured dose.
Before each measurement session the microDiamond detector was pre-irradiated with 10 Gy to
stabilise dose response to within 0.2%. The within-session dose response repeatability suggests
the between-session coefficient of repeatability can be attributed to set-up repeatability. As
previously mentioned in section 4.2.1, the smaller the active volume of a detector the greater
the sensitivity to set-up errors. The microDiamond detector has the smallest active volume
(4×10−6 cc) of all detectors investigated in this study. The sensitive volume of the microDia-
mond detector is only 1 µm thick along the axis of the chamber, resulting in very high spatial
resolution. Therefore, small deviations in set up between sessions will effectively result in the
measurement of spatially separate point doses, with no overlap due to volume averaging.
4.3 Plan Complexity
This section evaluates the relationship between complexity metrics and point dose discrepancy
results, and examines the influence of detector and calculation algorithm choice on the cor-
relation of complexity metrics with point dose discrepancy. Selected plan parameters were
characterised via the use of complexity metrics, and point dose measurements were used to
evaluate the agreement between calculated and delivered isocentre dose. The complexity
metrics were developed under the assumption that increased plan complexity leads to increased
uncertainty in VMAT dose calculation and treatment delivery. A selection of established
complexity metrics previously published in the literature have been implemented and evaluated
against point dose measurement results for all detectors. Novel metrics quantifying MLC
perimeter and aperture characteristics, dose rate variation, and the fraction of beam blocked
by MLC were also implemented and evaluated. The calculation of plan complexity within a
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ROI centred on the measurement point, in order to increase the applicability of complexity
metrics for point quality assurance, was investigated for both established and novel metrics.
The strength and significance of correlation results for these metrics will be discussed.
Point doses have been calculated for both 4 degree and 2 degree per control point gantry spacing
in Pinnacle. Differences in correlations with complexity metrics for each calculation method
will be highlighted. The influence of dose calculation algorithm on the relationship between
complexity metrics and point dose discrepancy has been investigated.
4.3.1 Established Metrics
The correlation coefficients presented in table 3.5 show significant relationships exist between
established complexity metrics. The prostate target volume is roughly spherical about the
isocentre; a high proportion of MLC leaves crossing the central axis indicates the presence
of irregular fields. Metrics associated with field aperture irregularity (PI, CAS, MAD, and
CLS) are strongly correlated as expected. Similarly the strong correlation between the MCSv
derived metrics and PM can be explained due to the similarities between calculation of PM
and the AAV (one of the two components of the MCSv).The PMU allows the comparison of
MU for plans of different prescriptions. The PMU was found to have moderate and strong
correlations with all metrics (aside from MFA), confirming the relationship between plan MU
and complexity.
The correlation analysis between complexity metrics and point dose discrepancy discussed in
this section is based on doses calculated using the Pinnacle algorithm with 2 degree gantry
spacing. This represents the ’gold standard’ calculation for this study, as discussed in section 3.2.
Pearson correlation coefficient calculation results for the established metrics are summarised
in table 3.6. There exists no statistically significant correlation for LT, LTMCSv, MFA, SAS,
and PMU metrics for any detector investigated. Significant correlations with deliverability
metrics, MCSv and PM, are only observed for the CC04 measured results. The direction of the
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correlation indicates increased dose discrepancy for increasing modulation.
The strongest correlations for each of the ionisation chambers was seen for the PI metric.
Plans consisting of many narrow and/or irregular apertures achieve higher than average PI
values. Narrow apertures, like small fields, present challenges for accurate dose measurement
due to lateral charged particle disequilibrium [67]. The difficulty of dose calculation in long
narrow fields is well documented [11, 68]. A high proportion of long narrow fields leads to an
overestimation of output factor [69]. Both ionisation chamber measurement results also show
significant correlation with the CLS and MAD accuracy metrics. These metrics quantify the
proportion of segments for which deficiencies in MLC modelling, including tongue-and-groove
and leaf end effects, could become apparent [70, 71]. A significant relationship between MU
and the microDiamond detector was observed. No significant relationships were observed for
any of the established complexity metrics and the diodes.
These results suggest that the utility of specific complexity metrics is strongly dependent on
detector choice. The cause of the difference in complexity metric correlation results between the
ionisation chambers and other detectors is not clear as calculation and measurement inaccuracies
are combined in point dose discrepancy analysis.
4.3.2 Localised Complexity and Novel Metrics
The strength of correlations calculated in this study are much lower than has previously been
reported in the literature, when metrics are correlated with gamma analysis results [72–74].
Correlation of whole field complexity with dose to a point is problematic as equal weighting is
given to all MLC leaves during the complexity calculation. This motivated the investigation
of local complexity about the measurement point. The following established metrics were
recalculated in square regions of interest about the isocentre, as illustrated in figure 2.1: LT,
MCSv, LTMCSv, CAS, CLS, and SAS with thresholds of 2 mm to 20 mm.
Localised complexity analysis may be useful for the evaluation and identification of detector
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performance and limitations. When LT is calculated over the whole treatment field, no signif-
icant relationships are observed. But when the ROI is reduced to less than 3 cm around the
measurement point, significant correlations are observed for the EFD. This is possibly due to
the significant energy dependent response of the unshielded diode. Interaction of the beam with
MLC leaves causes a shift in energy spectrum of radiation incident on the detector, through
MLC leaf scatter and transmission [75]. High leaf travel about the measurement point therefore
indicates proportionally higher spectral variation of incident radiation.
The influence of volume averaging for ionisation chamber results was investigated by calculat-
ing the BF and SAS metrics with decreasing ROI. Table 3.8 shows significant relationships
with BF are only found for the CC04 chamber. Increased correlation strength is observed for
SAS calculations with decreased ROI for both the CC01 and CC04 ionisation chambers. This
trend is not observed for the other detectors, highlighting the relationship between detector
active volume size and volume averaging. The influence of detector occlusion was investigated
by the calculation of CAS with 1 cm ROI; no significant increase in the strength of correlations
was observed for any detector.
4.3.3 Influence of Calculation Method
As discussed in section 4.1, the choice of calculation algorithm has a significant influence
on final calculated dose. The point dose discrepancy calculations, against which complexity
metrics have been evaluated in this study, are therefore dependent on calculation algorithm.
When 4 degree per control point gantry spacing was used for dose calculation, no statistically
significant relationships were found between the established metrics introduced in section 2.3.1
and point dose discrepancy measured with any detector. Masi et al. investigated the impact of
control point spacing on gamma pass rates for VMAT by re-optimising high leaf travel plans at
2 and 3 degree gantry spacing [45]. The study showed that correlation strength decreased when
using finer control point spacing, leading the authors to conclude the dosimetric accuracy of
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high leaf travel plans is improved with reduction of gantry spacing angle. But the Masi et al.
study differs from the work presented in this study as the plans were re-optimised with finer
gantry spacing rather than recalculated with interpolated control points. The authors justified
this approach by calculating mean complexity metric (LT, MCSv, LTMCSv, and MU) values
and finding no statistically significant difference between the two plan cohorts.
Recalculation of the Pinnacle optimised treatment plans in RayStation was undertaken to
investigate the influence of an entirely independent beam model on the relationship between
complexity metrics and dose discrepancy. A summary of the RayStation beam model is
presented in section 2.2.2, which is modelled on an independently measured set of beam
data. Although there exists a systematic offset between RayStation calculated and measured
doses, correlation analysis is still useful to identify significant relationships between plan
parameters and point dose discrepancy. Table 3.9 shows that only the CLS metric has a
significant relationship with point dose discrepancy. As mentioned in section 4.3.1, the CLS
metric identifies calculation conditions which stress the accuracy of MLC modelling. Like the
Pinnacle 2 degree gantry spacing results for CLS, significant relationships only exist for the
ionisation chamber measurements. Anomalous ionisation chamber response has been observed
for measurements made under MLC leaves [76]. The influence of ionisation chamber response
in blocked fields over a full VMAT delivery is not significant, due to the very small amount of
dose deposited through blocked leaves as a proportion of total dose measured.
Strong correlations with small field complexity metrics (MFA and SAS) for the original
Pinnacle beam model can be seen in table 3.10. Statistically significant relationships between
point dose discrepancy and MFA exist for both ionisation chambers and the EFD detector. The
small field beam data, for which the model was generated, was measured using detectors now
known to be less suitable for small field dosimetry. A new set of beam data was measured,
using the microDiamond detector following current small field dosimetry guidelines, for the
creation of the updated Pinnacle beam model. Table 3.6 shows no significant relationships
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were found for small field complexity metrics and dose discrepancy for the new Pinnacle beam
model. These results suggest complexity metrics can be used to identify deficiencies in beam
modelling and dose calculation algorithm performance.
4.4 Future Work
One limitation of this study was the selection of plans from a single anatomical site. The choice
to investigate only prostate treatment plans was motivated by several factors; uniformity of
target volume shape between plans, ease of measurement position choice, and the high numbers
of clinically delivered prostate plans available for investigation at Auckland City Hospital.
The geometry of the target volume is relatively uniform from plan-to-plan for prostate treat-
ments, when compared to head and neck plans for example. Previous studies have shown
complexity metric values are correlated with treatment site, therefore comparison of complexity
values between sites is muddied by the intrinsic complexity requirements of different treatment
sites. Extension of complexity analysis to other sites would increase the range of complexity
metric results, sites associated with both higher and lower complexity should be investigated.
For example, head and neck treatment plans have generally been found to require higher
modulation to achieve clinical objectives.
Localised complexity analysis within a ROI around the measurement point was introduced
to increase the sensitivity of complexity metrics around the measurement point. Modulation
of the beam in regions far from the measurement point is included in full-field complexity
metric calculations. This modulation is likely to have little influence on the dose delivered to
the measurement point, effectively diluting the relationship between complexity metrics and
point dose discrepancy. The usefulness of ROI based complexity calculation may increase for
treatment plans for sites with larger target volumes, and therefore larger treatment field size.
The selection of measurement point for point dose measurements is crucial. Current best
practice is to select a measurement point within a homogeneous high dose region, away from
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steep dose gradients [77]. The isocentre is typically a suitable point for prostate VMAT plans.
The PTV is roughly circular in shape and relatively uniform between plans, allowing for simple
measurement set up without having to apply detector shifts. Positioning of detectors off-axis
in solid phantoms can lead to larger set-up inaccuracy [59]. A suitable measurement point,
that is in a homogeneous region of high dose, may be unachievable for plans with especially
modulated beam fluence where steep dose gradients are present throughout.
Receiver operating characteristic (ROC) analysis was not undertaken to investigate threshold
complexity values in order to classify plans as deliverable or un-deliverable. All plans investi-
gated in this study were clinically acceptable and passed quality assurance. The inclusion and
analysis of plans which have failed quality assurance may be useful in identification of both
delivery and dose calculation algorithm limitations.
A recent paper by Valdes et al. proposed a mathematical framework for the application of
machine learning techniques to IMRT/VMAT quality assurance, with the goal of predicting
gamma passing rates [78]. The key advantage of adopting a machine learning approach is the
integration of many complexity metrics into a single model. The correlation analysis presented
in this study has been performed using a single metric at a time, but it is unlikely that a single
metric will be able to characterise all of the discrepancy between calculated and measured dose.
The determination of each complexity metric weighting in the machine learning algorithm
is unique for each beam quality and linear accelerator at each department. This accounts for
differences in the relationship between complexity metrics and point dose discrepancy between
detectors and calculation algorithms seen in this study. The machine learning based algorithm
was able to predict gamma passing rates to within 3% for all 498 IMRT plans analysed. This
machine learning approach could be applied to point dose discrepancy results and would allow
the identification of key plan parameters and characterise their interaction.
Chapter 5
Conclusion
Patient specific quality assurance is an essential requirement for IMRT and VMAT treatments.
Plan verification measurements, including point dose measurements, account for a significant
fraction of the overall physics workload. Optimisation of the patient specific QA process is
essential as the proportion of patients receiving IMRT and VMAT treatments is increasing.
This study has shown that both the dose calculation algorithm and the choice of detector
influence the point dose discrepancy results. A statistically significant difference was found
between doses calculated in Pinnacle with 4 degree gantry spacing, which is used clinically,
and interpolated 2 degree control points. The suitability of five detectors has been investigated
through evaluation of measurement repeatability and agreement with treatment planning system
calculations. The ionisation chambers (CC01 and CC04) and unshielded diode (EFD) have
been identified as the most suitable detectors for point dose measurements for VMAT patient
specific QA. All three detectors achieved excellent repeatability; agreement between measured
and calculated dose was highest for the EFD and CC01 detectors.
Plan complexity was quantified through the use of complexity metrics - both established and
novel complexity metrics were calculated. Correlation analysis was undertaken to quantify the
relationship between point dose discrepancy and plan complexity metrics. The calculation of
complexity constrained to a region of interest centred around the measurement and calculation
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point increased the sensitivity of some complexity metrics. Detector choice for the point
dose discrepancy calculation was shown to influence correlation with complexity metrics.
Statistically significant relationships between point dose discrepancy results and complexity
metrics were found for only the CC01, CC04, and microDiamond detectors. Likewise, the
choice of calculation algorithm is significant; no significant correlations were found when dose
was calculated in Pinnacle with 4 degree gantry angle spacing.
Although statistically significant relationships between complexity metrics and point dose
discrepancy were found, the strength of these relationships are not sufficient to reliably predict
plans likely to fail quality assurance. Therefore, direct measurement of VMAT treatment plans
remains an essential component of patient specific quality assurance at Auckland City Hospital.
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Appendix A
Calculation of Complexity Metrics
This section summarises how a selection of established complexity metrics have been calculated
in this study, for a more complete treatment please see references [47, 74].
Let xA,i jk represent the position of kth leaf of jth control point of ith beam in MLC bank A.
Let xmax,B,i j represent the maximum positional change of MLC positions, that is
xmax,B,i j = max(xB,i j)−min(xB,i j) (A.1)

















xmax,A,i j −|xA,i j − xA,i j(k+1)|
)
(A.2)
where K is the number of exposed MLC leaves per bank.
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where U(AAi j) is the union area of all segments in beam i.
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where MUp is the total MU for the plan.



















where d is the prescribed dose per fraction

Appendix B
Point Dose Repeatability Measurements
Figures B.1 to B.4 show for each detector across all measurement sessions paired differences
are not dependent on their mean, therefore we can conclude the standard deviation of errors is
independent of the true ’error-free’ value.
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Fig. B.1 Bland-Altman plot of paired differences against mean between measurement sessions
for the CC01 detector.
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Fig. B.2 Bland-Altman plot of paired differences against mean between measurement sessions
for the CC04 detector.
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Fig. B.3 Bland-Altman plot of paired differences against mean between measurement sessions
for the EFD detector.
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Fig. B.4 Bland-Altman plot of paired differences against mean between measurement sessions
for the PFD detector.
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Fig. B.5 Bland-Altman plot of paired differences against mean between measurement sessions
for the microDiamond detector.
